Dr. Achim Regenauer is a specialist in internal medicine with many years of experience in clinical medicine before he joined the reinsurance industry. During several decades he acquired knowledge in risk management of international life insurance (case assessment, development of guidelines, various forms and depths of underwriting, coaching, product counselling, claims, complaint management), partially also in health and non-life insurance. During this time, he worked internationally for Munich Re at an executive level with additional engagements in various insurance associations (e.g., Board Member of the ICLAM and Chairman of the board of Department for Life Insurance Medicine in Germany), but also with frequent contact to actuarial organisations, governments, and the media dealing with hot topics such as SARS or Avian influenza. In the last years, one of his major tasks was to monitor and to analyze non-financial trends in medicine, technology, society, and politics in terms of their impact on life and health insurance.

As from 1st January 2017 he joined PartnerRe as the Chief Medical Officer dealing with topical issues like the genomic revolution, digitization of health care, implications by COVID on insurance business, and emerging topics such as antimicrobial resistance, obesity, mental health, etc. Major focus of his activities are longevity issues, underwriting, claims, critical illness, critical advantage, and regular publications and updates on Partner Re manual PAR (underwriting manual).